1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with omega-n-methylarginine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dobrovol'skiĭ, FV; Rudyk, EV; Sagach, VF; Shimanskaia, TV; Strutinskaia, NA; vavilova, GL | 1 |
Choi, CL; Cui, W; Han, YF; Hu, SQ; Lee, MY; Mak, SH; Rong, JH; Tsim, WK; Wang, YQ; Xu, DP; Zhang, ZJ | 1 |
2 other study(ies) available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and omega-n-methylarginine
Article | Year |
---|---|
[No-dependent modulation of the sensitivity of the mitochondrial permeability transition pore opening under ischemia-reperfusion of the isolated heart].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Calcium; Cyclosporine; Dopamine Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guinea Pigs; Male; Mitochondria, Heart; Mitochondrial Membranes; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; omega-N-Methylarginine; Rats; Rats, Wistar; Voltage-Dependent Anion Channels | 2009 |
Sunitinib produces neuroprotective effect via inhibiting nitric oxide overproduction.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Animals, Newborn; Apoptosis; Cells, Cultured; Cerebellum; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Humans; Indazoles; Indoles; Neurons; Neuroprotective Agents; Neurotoxins; Nitric Oxide; omega-N-Methylarginine; Pyrroles; Rats; Rats, Sprague-Dawley; Sunitinib | 2014 |